Marcos Navares-Gómez

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 12

Top Venues

Clinical and translational science

Pharmaceutics

Human psychopharmacology

Journal of personalized medicine

Hospital Universitario La Princesa

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Hospital Universitario La Princesa Feb 18 2019

Spain

Técnico de Laboratorio - Investigador :: Farmacología Clínica; Laboratorio de Farmacogenética

Publications

Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science 17 (1) (2024)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Ana Casajús, Pablo Zubiaur, Enrique Alday, Paula Soria-Chacartegui, Miriam Saiz-Rodriguez, Lara Gutierrez, Catalina Aragonés, Diana María Campodónico, Antía Gómez-Fernández, Marcos Navares-Gómez, Gonzalo Villapalos-García, Gina Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Impact of CYP2D6 and CYP2B6 phenotypes on the response to tramadol in patients with acute post-surgical pain. Clinical and translational science (2023)
Diana María Campodónico, Pablo Zubiaur, Paula Soria-Chacartegui, Ana Casajús, Gonzalo Villapalos-García, Marcos Navares-Gómez, Antía Gómez-Fernández, Raúl Parra-Garcés, Gina P Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
CYP2C8*3 and *4 define CYP2C8 phenotype: An approach with the substrate cinitapride. Clinical and translational science 15 (11) (2022)
Paula Soria-Chacartegui, Gonzalo Villapalos-García, Luis A López-Fernández, Marcos Navares-Gómez, Gina P Mejía-Abril, Francisco Abad-Santos, Pablo Zubiaur
Clinical Relevance of Novel Polymorphisms in the Dihydropyrimidine Dehydrogenase ( DPYD ) Gene in Patients with Severe Fluoropyrimidine Toxicity: A Spanish Case-Control Study. Pharmaceutics 13 (12) (2021)
Pablo Zubiaur, Paula Fernández-Campos, Marcos Navares-Gómez, Paula Soria-Chacartegui, Gonzalo Villapalos-García, Manuel Román, Gina P Mejía-Abril, Dolores Ochoa, Francisco Abad-Santos
Variants in COMT, CYP3A5, CYP2B6, and ABCG2 Alter Quetiapine Pharmacokinetics. Pharmaceutics 13 (10) (2021)
Pablo Zubiaur, Maria Dolores Benedicto, Gonzalo Villapalos-García, Marcos Navares-Gómez, Gina Mejía-Abril, Manuel Román, Samuel Martín-Vílchez, Dolores Ochoa, Francisco Abad-Santos
SLCO1B1 Phenotype and CYP3A5 Polymorphism Significantly Affect Atorvastatin Bioavailability. Journal of personalized medicine 11 (3) (2021)
Pablo Zubiaur, Lisa A Kneller, Dolores Ochoa, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Alberto M Borobia, Dora Koller, Irene García García, Marcos Navares-Gómez, Georg Hempel, Francisco Abad-Santos
Evaluation of Voriconazole CYP2C19 Phenotype-Guided Dose Adjustments by Physiologically Based Pharmacokinetic Modeling. Clinical pharmacokinetics 60 (2) (2021)
Dora Koller, Susana Almenara, Gina P Mejía-Abril, Miriam Saiz-Rodriguez, Pablo Zubiaur, Manuel Román, Dolores Ochoa, Aneta Wojnicz, Samuel Martín, Daniel Romero-Palacián, Marcos Navares-Gómez, Francisco Abad-Santos
Safety and cardiovascular effects of multiple-dose administration of aripiprazole and olanzapine in a randomised clinical trial. Human psychopharmacology 36 (1) (2020)
Pablo Zubiaur, Dora Koller, Miriam Saiz-Rodriguez, Marcos Navares-Gómez, Francisco Abad-Santos
Important Pharmacogenetic Information for Drugs Prescribed During the SARS-CoV-2 Infection (COVID-19). Clinical and translational science 13 (6) (2020)

Marcos Navares-Gómez.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Marcos Navares-Gómez